DE69938555D1 - Impfstoff gegen geschlechtlich übertragene krankheiten - Google Patents

Impfstoff gegen geschlechtlich übertragene krankheiten

Info

Publication number
DE69938555D1
DE69938555D1 DE69938555T DE69938555T DE69938555D1 DE 69938555 D1 DE69938555 D1 DE 69938555D1 DE 69938555 T DE69938555 T DE 69938555T DE 69938555 T DE69938555 T DE 69938555T DE 69938555 D1 DE69938555 D1 DE 69938555D1
Authority
DE
Germany
Prior art keywords
transmissions
vaccine against
gender
against gender
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69938555T
Other languages
English (en)
Other versions
DE69938555T2 (de
Inventor
Moncef Mohamed Slaoui
Pierre G Vandepapeliere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69938555(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of DE69938555D1 publication Critical patent/DE69938555D1/de
Application granted granted Critical
Publication of DE69938555T2 publication Critical patent/DE69938555T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DE1999638555 1998-09-11 1999-09-08 Impfstoff gegen geschlechtlich übertragene krankheiten Expired - Lifetime DE69938555T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9819898 1998-09-11
GB9819898A GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use
PCT/EP1999/006623 WO2000015255A1 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases

Publications (2)

Publication Number Publication Date
DE69938555D1 true DE69938555D1 (de) 2008-05-29
DE69938555T2 DE69938555T2 (de) 2009-06-10

Family

ID=10838766

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1999638555 Expired - Lifetime DE69938555T2 (de) 1998-09-11 1999-09-08 Impfstoff gegen geschlechtlich übertragene krankheiten

Country Status (29)

Country Link
EP (1) EP1109574B1 (de)
JP (1) JP2002524532A (de)
KR (1) KR100777896B1 (de)
CN (2) CN1325311A (de)
AR (1) AR021798A1 (de)
AT (1) ATE392214T1 (de)
AU (1) AU744989B2 (de)
BR (1) BR9913630A (de)
CA (1) CA2343399C (de)
CO (1) CO5090882A1 (de)
CY (1) CY1108147T1 (de)
CZ (1) CZ302808B6 (de)
DE (1) DE69938555T2 (de)
DK (1) DK1109574T3 (de)
ES (1) ES2304068T3 (de)
GB (1) GB9819898D0 (de)
HK (1) HK1037978A1 (de)
HU (1) HUP0104297A3 (de)
IL (1) IL141843A0 (de)
MY (1) MY122216A (de)
NO (1) NO329522B1 (de)
NZ (1) NZ510425A (de)
PL (1) PL199545B1 (de)
PT (1) PT1109574E (de)
SI (1) SI1109574T1 (de)
TR (1) TR200100948T2 (de)
TW (1) TWI225790B (de)
WO (1) WO2000015255A1 (de)
ZA (1) ZA200101987B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000087I1 (de) 1998-10-16 2008-03-27 Glaxosmithkline Biolog Sa Adjuvanzsysteme und impfstoffe
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
WO2007081447A2 (en) 2005-11-22 2007-07-19 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
EP2368570A3 (de) 2006-01-18 2012-05-02 University Of Chicago Zusammensetzungen und Verfahren in Verbindung mit Stayphylokokken-Bakterienproteinen
ES2561483T3 (es) 2007-09-12 2016-02-26 Glaxosmithkline Biologicals Sa Antígenos mutantes de GAS57 y anticuerpos de GAS57
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
EP2443250B8 (de) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA Komplement-vermittelte antikörper-abhängige und opsonische bakterienassays mit hohem durchlauf
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
WO2011127360A1 (en) 2010-04-08 2011-10-13 University Of Pittsburgh-Of The Commonwealth System Of Higher Education B-cell antigen presenting cell assay
KR20130121699A (ko) 2010-05-28 2013-11-06 테트리스 온라인, 인코포레이티드 상호작용 혼성 비동기 컴퓨터 게임 기반구조
WO2013006569A2 (en) 2011-07-01 2013-01-10 The Regents Of The University Of California Herpes virus vaccine and methods of use
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
JP2017527610A (ja) 2014-07-07 2017-09-21 プロフィラクシス リミテッド ライアビリティ カンパニー ウイルス予防治療方法及び曝露前予防キット
KR20180115276A (ko) 2016-02-22 2018-10-22 베링거잉겔하임베트메디카게엠베하 생체 분자의 고정화 방법
WO2020086408A1 (en) 2018-10-26 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A high-yield perfusion-based transient gene expression bioprocess

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
DE69405551T3 (de) * 1993-03-23 2005-10-20 Smithkline Beecham Biologicals S.A. 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
GB9819898D0 (en) 1998-11-04
CN101130070A (zh) 2008-02-27
CO5090882A1 (es) 2001-10-30
IL141843A0 (en) 2002-03-10
CA2343399C (en) 2010-08-03
NO20011193D0 (no) 2001-03-08
HUP0104297A2 (hu) 2002-03-28
PL346651A1 (en) 2002-02-25
CA2343399A1 (en) 2000-03-23
BR9913630A (pt) 2001-05-22
DK1109574T3 (da) 2008-06-30
MY122216A (en) 2006-03-31
JP2002524532A (ja) 2002-08-06
ES2304068T3 (es) 2008-09-01
EP1109574A1 (de) 2001-06-27
NO329522B1 (no) 2010-11-01
EP1109574B1 (de) 2008-04-16
KR20010075049A (ko) 2001-08-09
NZ510425A (en) 2003-04-29
NO20011193L (no) 2001-05-09
CY1108147T1 (el) 2014-02-12
CZ302808B6 (cs) 2011-11-23
TR200100948T2 (tr) 2001-07-23
HUP0104297A3 (en) 2004-10-28
AR021798A1 (es) 2002-08-07
AU744989B2 (en) 2002-03-07
CN1325311A (zh) 2001-12-05
KR100777896B1 (ko) 2007-11-27
CZ2001887A3 (cs) 2001-10-17
TWI225790B (en) 2005-01-01
AU5975299A (en) 2000-04-03
ZA200101987B (en) 2002-05-09
WO2000015255A1 (en) 2000-03-23
PL199545B1 (pl) 2008-09-30
SI1109574T1 (sl) 2008-08-31
DE69938555T2 (de) 2009-06-10
ATE392214T1 (de) 2008-05-15
HK1037978A1 (en) 2002-03-01
PT1109574E (pt) 2008-06-12

Similar Documents

Publication Publication Date Title
DE60018950D1 (de) Gegen zusammendrücken beständige wellschlauchverbindung
ID25977A (id) Popok sekali pakai
DE69910909D1 (de) Fluorpolymerdispersionen
ID24555A (id) Popok sekali pakai
ID23076A (id) Popok sekali pakai
NO20021433L (no) Vaksiner
DE69926740D1 (de) Endoskop
ID26056A (id) Popok sekali pakai
DE10084662T1 (de) Mehrfachbahn-Verbinden
DE60021679D1 (de) Endoskop
DE59908145D1 (de) Endoskop
ID26389A (id) Popok sekali pakai
NO20006191D0 (no) Vaksine
ID23083A (id) Popok sekali pakai
DE69938555D1 (de) Impfstoff gegen geschlechtlich übertragene krankheiten
DE60022034D1 (de) Lastaufbau
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
DE60044049D1 (de) Axiallüfter
FR2778755B3 (fr) Endoscope
DE50015795D1 (de) Sektionaltor
DE60129876D1 (de) Optischer Tomograph
IS5694A (is) Bóluefni
DE50014453D1 (de) Texturiermaschine
NL1011488A1 (nl) Hoofdtelefoon-microfoon-combinatie.

Legal Events

Date Code Title Description
8363 Opposition against the patent